Dopamine antagonism inhibits anorectic behavior in an animal model for anorexia nervosa

European Neuropsychopharmacology

Volumn 19, Issue 3, 2009, Pages 153-160

  Verhagen, Linda A W ^a   Luijendijk, Mieneke C M ^a   Hillebrand, Jacquelien J G ^b,c   Adan, Roger A H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Altrecht Mental Health Institute   (Netherlands)

^c ETH ZURICH   (Switzerland)

Author keywords

Anorexia; Dopamine antagonism; Food restriction; Food anticipatory activity; Hyperactivity; Leptin

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPENTIXOL; OLANZAPINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA NERVOSA; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FOOD INTAKE; HYPERACTIVITY; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; ANOREXIA NERVOSA; BEHAVIOR, ANIMAL; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; EATING; FEMALE; FLUPENTHIXOL; FOOD DEPRIVATION; INSULIN; LEPTIN; MOTOR ACTIVITY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR;

EID: 58949103838     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.09.005     Document Type: Article

References (41)

1. Allison D.B., and Casey D.E. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatry 62 Suppl 7 (2001) 22-31
2. Bailer U.F., Frank G.K., Henry S.E., Price J.C., Meltzer C.C., Weissfeld L., et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch. Gen. Psychiatry 62 (2005) 1032-1041
3. Barbano M.F., and Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology (Berl) 191 (2007) 497-506
4. Barbarich N.C., McConaha C.W., Gaskill J., La Via M., Frank G.K., Achenbach S., et al. An open trial of olanzapine in anorexia nervosa. J. Clin. Psychiatry 65 (2004) 1480-1482
5. Barry V.C., and Klawans H.L. On the role of dopamine in the pathophysiology of anorexia nervosa. J. Neural Transm. 38 (1976) 107-122
6. Bergen A.W., Yeager M., Welch R.A., Haque K., Ganjei J.K., van den Bree M.B., et al. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 30 (2005) 1703-1710
7. Bulik C.M., Slof-Op't Landt M.C., van Furth E.F., and Sullivan P.F. The genetics of anorexia nervosa. Annu. Rev. Nutr. 27 (2007) 263-275
8. Casper R.C., Schoeller D.A., Kushner R., Hnilicka J., and Gold S.T. Total daily energy expenditure and activity level in anorexia nervosa. Am. J. Clin. Nutr. 53 (1991) 1143-1150
9. Casper R.C., Sullivan E.L., and Tecott L. Relevance of animal models to human eating disorders and obesity. Psychopharmacology (Berl) 199 (2008) 313-329
10. Dally P., and Sargant W. Treatment and outcome of anorexia nervosa. Br. Med. J 2 (1966) 793-795
11. Davis C. Eating disorders and hyperactivity: a psychobiological perspective. Can. J. Psychiatry 42 (1997) 168-175
12. Frank G.K., Kaye W.H., Meltzer C.C., Price J.C., Greer P., McConaha C., and Skovira K. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol. Psychiatry 52 (2002) 896-906
13. Frank G.K., Bailer U.F., Henry S.E., Drevets W., Meltzer C.C., Price J.C., et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol. Psychiatry 58 (2005) 908-912
14. Fumeron F., Betoulle D., Aubert R., Herbeth B., Siest G., and Rigaud D. Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol. Psychiatry 6 (2001) 9-10
15. Hebebrand J., Exner C., Hebebrand K., Holtkamp C., Casper R.C., Remschmidt H., et al. Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol. Behav. 79 (2003) 25-37
16. Hillebrand J.J., Koeners M.P., de Rijke C.E., Kas M.J., and Adan R.A. Leptin treatment in activity-based anorexia. Biol. Psychiatry 58 (2005) 165-171
17. Hillebrand J.J., van Elburg A.A., Kas M.J., van Engeland H., and Adan R.A. Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?. Biol. Psychiatry 58 (2005) 651-657
18. Holtkamp K., Hebebrand J., and Herpertz-Dahlmann B. The contribution of anxiety and food restriction on physical activity levels in acute anorexia nervosa. Int. J. Eat. Disord. 36 (2004) 163-171
19. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51 (2006) 801-810
20. Kaye W.H., Gwirtsman H.E., Obarzanek E., and George D.T. Relative importance of calorie intake needed to gain weight and level of physical activity in anorexia nervosa. Am. J. Clin. Nutr. 47 (1988) 989-994
21. Kron L., Katz J.L., Gorzynski G., and Weiner H. Hyperactivity in anorexia nervosa: a fundamental clinical feature. Compr. Psychiatry 19 (1978) 433-440
22. Lambert K.G., and Porter J.H. Pimozide mitigates excessive running in the activity-stress paradigm. Physiol. Behav. 52 (1992) 299-304
23. Leibowitz S.F., and Brown L.L. Histochemical and pharmacological analysis of catecholaminergic projections to the perifornical hypothalamus in relation to feeding inhibition. Brain Res. 201 (1980) 315-345
24. Malina A., Gaskill J., McConaha C., Frank G.K., LaVia M., Scholar L., and Kaye W.H. Olanzapine treatment of anorexia nervosa: a retrospective study. Int. J. Eat. Disord. 33 (2003) 234-237
25. McCullough L.D., and Salamone J.D. Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study. Brain Res. 592 (1992) 29-36
26. Mistlberger R.E. Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci. Biobehav. Rev. 18 (1994) 171-195
27. Mistlberger R.E., and Mumby D.G. The limbic system and food-anticipatory circadian rhythms in the rat: ablation and dopamine blocking studies. Behav. Brain Res. 47 (1992) 159-168
28. Myers M.G., Cowley M.A., and Munzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70 (2008) 537-556
29. Porte Jr. D., Baskin D.G., and Schwartz M.W. Leptin and insulin action in the central nervous system. Nutr. Rev. 60 (2002) S20-S29
30. Powers P.S., Santana C.A., and Bannon Y.S. Olanzapine in the treatment of anorexia nervosa: an open label trial. Int. J. Eat. Disord. 32 (2002) 146-154
31. Reilly T.M. Central dopamine blockade in anorexia nervosa. Br. Med. J. 1 (1978) 367-368
32. Ricca V., Nacmias B., Cellini E., di Bernardo M., Rotella C.M., and Sorbi S. 5-HT2A receptor gene polymorphism and eating disorders. Neurosci. Lett. 323 (2002) 105-108
33. Roth B.L., Sheffler D.J., and Kroeze W.K. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3 (2004) 353-359
34. Routtenberg A. "Self-starvation" of rats living in activity wheels: adaptation effects. J. Comp. Physiol. Psychol. 66 (1968) 234-238
35. Routtenberg A., and Kuznesof A.W. Self-starvation of rats living in activity wheels on a restricted feeding schedule. J. Comp. Physiol. Psychol. 64 (1967) 414-421
36. Szczypka M.S., Mandel R.J., Donahue B.A., Snyder R.O., Leff S.E., and Palmiter R.D. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice. Neuron 22 (1999) 167-178
37. Szczypka M.S., Rainey M.A., Kim D.S., Alaynick W.A., Marck B.T., Matsumoto A.M., and Palmiter R.D. Feeding behavior in dopamine-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12138-12143
38. Thornton-Jones Z., Neill J.C., and Reynolds G.P. The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. J. Psychopharmacol. 16 (2002) 35-37
39. Vandereycken W., and Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatr. Scand. 66 (1982) 445-450
40. Watanabe K., Hara C., and Ogawa N. Feeding conditions and estrous cycle of female rats under the activity-stress procedure from aspects of anorexia nervosa. Physiol Behav. 51 (1992) 827-832
41. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83 (1995) 1197-1209